CG Oncology Director Leonard E. Post Reports Sale of Common Shares Worth $62,065

• CG Oncology director Leonard E. Post sold 1,000 common shares on Oct. 15, 2026.
• The sales comprised 500 shares at $61.65 each and 500 shares at $62.48 each.
• Post also exercised director stock options for 1,000 common shares at $0.60 each that day.
• Following the transactions, he held no common stock directly; his remaining director stock options covered 102,077 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-425295), on October 19, 2026, and is solely responsible for the information contained therein.